Niaspan treatment improves neurological functional recovery in experimental autoimmune encephalomyelitis mice

Neurobiology of Disease

Volumn 32, Issue 2, 2008, Pages 273-280

  Zhang, Jing ^a   Chen, Jieli ^a   Li, Yi ^a   Cui, Xu ^a   Zheng, Xuguang ^a   Roberts, Cynthia ^a   Lu, Mei ^b   Elias, Stanton B ^a   Chopp, Michael ^a,c  

^a HENRY FORD HOSPITAL   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c OAKLAND UNIVERSITY   (United States)

Author keywords

Axon; Demyelination; Experimental autoimmune encephalomyelitis; High density lipoprotein; Niacin; Niaspan; Oligodendrocyte cell; Oligodendrogenesis; Sonic hedgehog

Indexed keywords

HIGH DENSITY LIPOPROTEIN; MYELIN; NICOTINIC ACID; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CONVALESCENCE; FEMALE; INFLAMMATORY INFILTRATE; LIPOPROTEIN BLOOD LEVEL; MOUSE; NERVE CELL CULTURE; NERVE FIBER REGENERATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD;

ANIMALS; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CHOLESTEROL, HDL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HEDGEHOG PROTEINS; MICE; MYELIN PROTEOLIPID PROTEIN; NERVE REGENERATION; NIACIN; OLIGODENDROGLIA; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION; SPINAL CORD; TIME FACTORS; VITAMIN B COMPLEX;

EID: 53749086273     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.07.011     Document Type: Article

References (75)

1. Adams C.W., and Abdulla Y.H. The action of human high density lipoprotein on cholesterol crystals. Part 1. Light-microscopic observations. Atherosclerosis 31 (1978) 465-471
2. Ahn S., and Joyner A.L. In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog. Nature 437 (2005) 894-897
3. Allamargot C., and Gardinier M.V. Alternative isoforms of myelin/oligodendrocyte glycoprotein with variable cytoplasmic domains are expressed in human brain. J. Neurochem. 101 (2007) 298-312
4. Althaus H.H., et al. Nerve growth factor induces proliferation and enhances fiber regeneration in oligodendrocytes isolated from adult pig brain. Neurosci. Lett. 135 (1992) 219-223
5. Barter P.J., et al. Antiinflammatory properties of HDL. Circ. Res. 95 (2004) 764-772
6. Battiste J., et al. Ascl1 defines sequentially generated lineage-restricted neuronal and oligodendrocyte precursor cells in the spinal cord. Development 134 (2007) 285-293
7. Birjmohun R.S., et al. Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice. Neth. J. Med. 62 (2004) 229-234
8. Boullerne A.I., et al. Role of calcium in nitric oxide-induced cytotoxicity: EGTA protects mouse oligodendrocytes. J. Neurosci. Res. 63 (2001) 124-135
9. Boyles J.K., et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest. 83 (1989) 1015-1031
10. Cafferty W.B., et al. Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J. Neurosci. 24 (2004) 4432-4443
11. Calabresi L., et al. Endothelial protection by high-density lipoproteins: from bench to bedside. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1724-1731
12. Campagnoni C.W., et al. Identification of genes in the oligodendrocyte lineage through the analysis of conditionally immortalized cell lines. Dev. Neurosci. 23 (2001) 452-463
13. Capuzzi D.M., et al. Efficacy and safety of an extended-release niacin (Niaspan): a long-term study. Am. J. Cardiol. 82 (1998) 74U-81U discussion 85U-86U
14. Carlson L.A. Niaspan, the prolonged release preparation of nicotinic acid (niacin), the broad-spectrum lipid drug. Int. J. Clin. Pract. 58 (2004) 706-713
15. Carroll W.M., and Jennings A.R. Early recruitment of oligodendrocyte precursors in CNS demyelination. Brain 117 Pt. 3 (1994) 563-578
16. Chang A., et al. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J. Neurosci. 20 (2000) 6404-6412
17. Chen J., et al. Niaspan increases angiogenesis and improves functional recovery after stroke. Ann. Neurol. 62 (2007) 49-58
18. Dubois-Dalcq M., and Murray K. Why are growth factors important in oligodendrocyte physiology?. Pathol. Biol. (Paris) 48 (2000) 80-86
19. Ffrench-Constant C., and Raff M.C. Proliferating bipotential glial progenitor cells in adult rat optic nerve. Nature 319 (1986) 499-502
20. Foster L.M., et al. Conditionally immortalized oligodendrocyte cell lines migrate to different brain regions and elaborate 'myelin-like' membranes after transplantation into neonatal shiverer mouse brains. Dev. Neurosci. 17 (1995) 160-170
21. Garcia C.I., et al. Differential gene expression during development in two oligodendroglial cell lines overexpressing transferrin: a cDNA array analysis. Dev. Neurosci. 29 (2007) 413-426
22. Genain C.P., et al. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5 (1999) 170-175
23. Gensert J.M., and Goldman J.E. In vivo characterization of endogenous proliferating cells in adult rat subcortical white matter. Glia 17 (1996) 39-51
24. Gensert J.M., and Goldman J.E. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 19 (1997) 197-203
25. Godfraind C., et al. In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice. J. Cell. Biol. 109 (1989) 2405-2416
26. Gold R., et al. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129 (2006) 1953-1971
27. Goldberg A.C. Clinical trial experience with extended-release niacin (Niaspan): dose-escalation study. Am. J. Cardiol. 82 (1998) 35U-38U discussion 39U-41U
28. Goti D., et al. Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E. J. Neurochem. 76 (2001) 498-508
29. Guyton J.R. Extended-release niacin for modifying the lipoprotein profile. Expert. Opin. Pharmacother. 5 (2004) 1385-1398
30. Guyton J.R., et al. Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia. Am. J. Cardiol. 82 (1998) 737-743
31. Hemmer B., et al. New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 3 (2002) 291-301
32. Hu Y., et al. Synergistic interactions of lipids and myelin basic protein. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 13466-13471
33. Ingham P.W., and McMahon A.P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15 (2001) 3059-3087
34. Jiang S., et al. Remyelination after chronic spinal cord injury is associated with proliferation of endogenous adult progenitor cells after systemic administration of guanosine. Purinergic. Signal 4 (2008) 61-71
35. Keirstead H.S., et al. Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 22 (1998) 161-170
36. Knopp R.H., et al. Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia. Metabolism 47 (1998) 1097-1104
37. Kuhlmann T., et al. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125 (2002) 2202-2212
38. Lassmann H. Axonal injury in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 74 (2003) 695-697
39. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
40. Lucchinetti C., et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47 (2000) 707-717
41. Ludwin S.K. An autoradiographic study of cellular proliferation in remyelination of the central nervous system. Am. J. Pathol. 95 (1979) 683-696
42. Ludwin S.K. Proliferation of mature oligodendrocytes after trauma to the central nervous system. Nature 308 (1984) 274-275
43. Marti E., and Bovolenta P. Sonic hedgehog in CNS development: one signal, multiple outputs. Trends Neurosci. 25 (2002) 89-96
44. Mastronardi F.G., et al. The amount of sonic hedgehog in multiple sclerosis white matter is decreased and cleavage to the signaling peptide is deficient. Mult. Scler. 9 (2003) 362-371
45. Merchan P., et al. Sonic hedgehog promotes the migration and proliferation of optic nerve oligodendrocyte precursors. Mol. Cell. Neurosci. 36 (2007) 355-368
46. Morgan J.M., et al. A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients. Am. J. Cardiol. 82 (1998) 29U-34U discussion 39U-41U
47. Murray K., et al. Sonic hedgehog is a potent inducer of rat oligodendrocyte development from cortical precursors in vitro. Mol. Cell. Neurosci. 19 (2002) 320-332
48. Nakashima Y., and Suzue R. Effect of nicotinic acid on myelin lipids in brain of developing rat. J. Nutr. Sci. Vitaminol. (Tokyo) 28 (1982) 491-500
49. Nery S., et al. Sonic hedgehog contributes to oligodendrocyte specification in the mammalian forebrain. Development 128 (2001) 527-540
50. Newman S.L., et al. Myelinogenic potential of an immortalized oligodendrocyte cell line. J. Neurosci. Res. 40 (1995) 680-693
51. Orentas D.M., et al. Sonic hedgehog signaling is required during the appearance of spinal cord oligodendrocyte precursors. Development 126 (1999) 2419-2429
52. Paez P.M., et al. Apotransferrin promotes the differentiation of two oligodendroglial cell lines. Glia 46 (2004) 207-217
53. Paez P.M., et al. Overexpression of human transferrin in two oligodendroglial cell lines enhances their differentiation. Glia 52 (2005) 1-15
54. Paez P.M., et al. Expression of myelin basic protein in two oligodendroglial cell lines is modulated by apotransferrin through different transcription factors. J. Neurosci. Res. 83 (2006) 606-618
55. Parras C.M., et al. Mash1 specifies neurons and oligodendrocytes in the postnatal brain. EMBO J. 23 (2004) 4495-4505
56. Posse De Chaves E.I., et al. Uptake of lipoproteins for axonal growth of sympathetic neurons. J. Biol. Chem. 275 (2000) 19883-19890
57. Prayoonwiwat N., and Rodriguez M. The potential for oligodendrocyte proliferation during demyelinating disease. J. Neuropathol. Exp. Neurol. 52 (1993) 55-63
58. Prineas J.W., et al. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab. Invest. 61 (1989) 489-503
59. Raff M.C., et al. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303 (1983) 390-396
60. Raine C.S., et al. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab. Invest. 45 (1981) 534-546
61. Raine C.S., et al. Oligodendrocyte proliferation and enhanced CNS remyelination after therapeutic manipulation of chronic relapsing EAE. Ann. N. Y. Acad. Sci. 540 (1988) 712-714
62. Rodriguez M. Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells. Lab. Invest. 64 (1991) 358-370
63. Ruiz i Altaba A., et al. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat. Rev. Cancer 2 (2002) 361-372
64. Seifert T., et al. Differential expression of sonic hedgehog immunoreactivity during lesion evolution in autoimmune encephalomyelitis. J. Neuropathol. Exp. Neurol. 64 (2005) 404-411
65. Stewart J.E., et al. Receptor binding of an apolipoprotein E-rich subfraction of high density lipoprotein to rat and human brain membranes. Int. J. Biochem. Cell. Biol. 30 (1998) 407-415
66. Studzinski D.M., and Benjamins J.A. Cyclic AMP differentiation of the oligodendroglial cell line N20.1 switches staurosporine-induced cell death from necrosis to apoptosis. J. Neurosci. Res. 66 (2001) 691-697
67. Studzinski D.M., et al. Increased intracellular calcium alters myelin gene expression in the N20.1 oligodendroglial cell line. J. Neurosci. Res. 57 (1999) 633-642
68. Sussman C.R., et al. Extracellular and intracellular regulation of oligodendrocyte development: roles of Sonic hedgehog and expression of E proteins. Glia 40 (2002) 55-64
69. Verity A.N., et al. Expression of myelin protein genes and other myelin components in an oligodendrocytic cell line conditionally immortalized with a temperature-sensitive retrovirus. J. Neurochem. 60 (1993) 577-587
70. Vick R.S., et al. Role of adult oligodendrocytes in remyelination after neural injury. J. Neurotrauma. 9 Suppl. 1 (1992) S93-S103
71. Vogt A., et al. Evaluation of the safety and tolerability of prolonged-release nicotinic acid in a usual care setting: the NAUTILUS study. Curr. Med. Res. Opin. 22 (2006) 417-425
72. Wang L., et al. The Sonic hedgehog pathway mediates carbamylated erythropoietin-enhanced proliferation and differentiation of adult neural progenitor cells. J. Biol. Chem. 282 (2007) 32462-32470
73. Zhang J., et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp. Neurol. 195 (2005) 16-26
74. Zhang J., et al. Erythropoietin treatment improves neurological functional recovery in EAE mice. Brain Res. 1034 (2005) 34-39
75. Zhang J., et al. Bone marrow stromal cells protect oligodendrocytes from oxygen-glucose deprivation injury. J. Neurosci. Res. 86 (2008) 1501-1510